Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm Receives Ethics Approval for Ross River Trial

May 22, 2017 at 3:04 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment